People rarely search for immunotherapy in the abstract. They search after a diagnosis has been given, or while supporting someone who has just received one, and the real question is narrower: does this apply to my condition. This article works through the conditions where immunotherapy is used or actively studied, condition by condition, and is honest about where the evidence is strong and where it is early. The foundations of how these treatments work are covered separately in what immunotherapy is and how it works.
The Question Behind the Search
A condition appearing on this list does not mean immunotherapy is the right treatment for a particular person with that condition. It means clinical evidence exists for that setting. Within any diagnosis, stage, previous treatment, organ function and biomarker results change the recommendation completely.
Read this as a map of where the research sits, then take it into a consultation with the specialist who holds your scans and pathology. That is where the decision belongs.
Conditions Immunotherapy Supports
| Condition | Approach studied or used | Evidence status |
|---|---|---|
| Non-small cell lung cancer | Checkpoint inhibitors, alone or with chemotherapy | Established in defined settings |
| Melanoma | Checkpoint inhibitors, combination regimens | Established |
| Bladder cancer | Intravesical BCG, checkpoint inhibitors | Established |
| Kidney cancer | Checkpoint inhibitor combinations | Established in advanced disease |
| Certain lymphomas and leukaemias | CAR-T therapy, monoclonal antibodies | Approved in specified settings |
| Head, neck, liver and gastric cancers | Checkpoint inhibitors | Approved in selected indications |
| Severe allergy and asthma | Allergen immunotherapy, targeted antibodies | Long established |
| Autoimmune conditions | Immune-modulating and cell-based approaches | Largely investigational outside approved biologics |
Lung Cancer
Lung cancer is where immunotherapy changed practice most visibly. Checkpoint inhibitors are now part of standard treatment in defined non-small cell lung cancer settings, used alone in some cases and combined with chemotherapy in others. Selection depends on stage, histology, molecular testing for driver mutations and on PD-L1 expression measured on the tumour sample.
Small cell lung cancer follows a different pathway with narrower immunotherapy use. Risk factors and early symptoms are covered in our article on lung cancer risks and preventive awareness.
Melanoma and Skin Cancers
Melanoma carries a high number of genetic alterations, which makes the cells comparatively visible to the immune system. That biology is why melanoma was among the first diseases where checkpoint inhibition became routine, both in advanced disease and after surgery in higher risk cases.
Some other skin cancers, including Merkel cell carcinoma and advanced squamous cell carcinoma, have defined immunotherapy indications as well. Dermatological surveillance remains the priority for anyone with a history of skin cancer.
Bladder and Kidney Cancer
Bladder cancer has one of the oldest immunotherapies in routine use: BCG instilled directly into the bladder for non-muscle-invasive disease, a treatment that predates the modern vocabulary by decades. Checkpoint inhibitors have since been added in defined advanced settings.
Kidney cancer responds poorly to conventional chemotherapy, which made immune approaches important earlier than in most solid tumours. Combination regimens pairing checkpoint inhibitors with targeted drugs are now standard in advanced disease.
Lymphoma and Blood Cancers
Blood cancers were the setting for the first approved CAR-T therapies, where a patient's own T cells are collected, genetically modified to recognise a marker on the cancer cells and returned by infusion. This is intensive treatment delivered in specialist centres with inpatient monitoring, because immune reactions can be severe and require immediate management.
Monoclonal antibodies have been part of lymphoma treatment far longer and are now unremarkable components of standard regimens.
Autoimmune and Allergic Conditions
Here the aim reverses. In cancer, the objective is to raise immune activity against a target. In autoimmune disease, the immune system is already overactive against the body's own tissue, and the objective is to rebalance it. Approved biologic drugs do this by blocking specific inflammatory signals, and allergen immunotherapy does it by retraining the response to a known allergen over months to years.
Cell-based approaches studied in autoimmune conditions aim at immune modulation rather than suppression, and remain investigational in most settings. Our article on stem cell therapy for autoimmune conditions looks at that evidence in detail, and plasmapheresis for autoimmune support in Bangkok covers the antibody-removal route.
How Suitability Is Assessed in Bangkok
At MRC Healthcare, an enquiry about immune-based care starts with document review rather than a treatment proposal. Our physicians ask for the pathology report, recent imaging, current medication list and the treatment plan your oncology or specialist team is already following. Blood work and organ function testing are arranged at our Bangkok facility where needed.
Where a supportive cell-based programme such as NK cell therapy or CIK therapy is discussed, its status is stated plainly, the schedule is written down, and nothing is positioned as a substitute for the treatment your specialist has planned. Some enquiries end with a recommendation to continue current care without adding anything, and that is a legitimate outcome.
Planning a Visit from Overseas
- Send pathology, imaging reports and medication lists before booking flights
- Expect an assessment visit before any programme is confirmed
- Ask how any proposed schedule interacts with treatment cycles already planned at home
- Confirm what written documentation you will take back to your specialist
- Agree who to contact if a reaction develops after you return
Patients travelling from Australia, Singapore, the United Kingdom, Europe and the Gulf can use our Thailand medical travel checklist for the practical steps around timing and documentation.
Related reading: immunotherapy side effects, warning signs and management and immunotherapy vs chemotherapy.
Ask Whether Immune-Based Care Applies to Your Condition
Share your diagnosis and recent reports with our medical team. You will get a direct answer about whether anything we offer has a sensible role alongside the treatment you are already receiving.
Schedule a Consultation
